Abstract | PURPOSE: MATERIALS AND METHODS: We performed this combination therapy in a total of 11 consecutive patients with previously untreated invasive squamous cell carcinoma (T2GC). Cisplatin was administered at 4 mg/m2/day and 5-FU at 200 mg/m2/day for 120 h, except during weekends, beginning on the day irradiation with a once-daily fraction at 2 Gy was started. RESULTS: An initial local control rate of the primary tumor was achieved in 10 of the 11 patients (91%), and ultimate laryngeal preservation by cordectomy was achieved in all cases. Regarding adverse reactions, grade 3 or 4 hemotoxicity did not develop in any of the patients. Grade 3 laryngitis was observed in four patients (36%), but none of these patients required interruption of treatment owing to acute laryngeal reactions. CONCLUSION:
|
Authors | Yoshiyuki Itoh, Nobukazu Fuwa |
Journal | Radiation medicine
(Radiat Med)
Vol. 24
Issue 4
Pg. 277-81
(May 2006)
ISSN: 0288-2043 [Print] Japan |
PMID | 16958401
(Publication Type: Journal Article)
|
Chemical References |
|
Topics |
- Aged
- Antineoplastic Combined Chemotherapy Protocols
(administration & dosage)
- Chemotherapy, Adjuvant
(methods)
- Cisplatin
(administration & dosage)
- Female
- Fluorouracil
(administration & dosage)
- Humans
- Infusions, Intravenous
- Laryngeal Neoplasms
(drug therapy, radiotherapy)
- Male
- Middle Aged
- Neoplasms, Squamous Cell
(drug therapy, radiotherapy)
- Retrospective Studies
- Treatment Outcome
- Vocal Cords
(drug effects, radiation effects)
|